{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:21:49Z","timestamp":1791397309097,"version":"4.3.3"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre, Poland","doi-asserted-by":"publisher","award":["2011\/01\/D\/NZ2\/03633"],"award-info":[{"award-number":["2011\/01\/D\/NZ2\/03633"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.gene.2017.10.064","type":"journal-article","created":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T01:15:17Z","timestamp":1508894117000},"page":"259-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Female Fabry disease patients and X-chromosome inactivation"],"prefix":"10.1016","volume":"641","author":[{"given":"Patrycja","family":"Juchniewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kloska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tylki-Szyma\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Jak\u00f3bkiewicz-Banecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"W\u0119grzyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Moskot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Gabig-Cimi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8899-2010","authenticated-orcid":false,"given":"Ewa","family":"Piotrowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2017.10.064_bb0005","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.gene.2017.10.064_bb0010","first-page":"1229","article-title":"Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation","volume":"51","author":"Allen","year":"1992","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.gene.2017.10.064_bb0015","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/507565","article-title":"X chromosome\u2013inactivation patterns of 1,005 phenotypically unaffected females","volume":"79","author":"Amos-Landgraf","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.gene.2017.10.064_bb0020","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00439-002-0676-8","article-title":"Variability of X chromosome inactivation: effect on levels of TIMP1 RNA and role of DNA methylation","volume":"110","author":"Anderson","year":"2002","journal-title":"Hum. Genet."},{"key":"10.1016\/j.gene.2017.10.064_bb0025","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/humu.1219","article-title":"Fabry disease: 20 novel GLA mutations in 35 families","volume":"18","author":"Blaydon","year":"2001","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.gene.2017.10.064_bb0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/8904_2011_63","article-title":"Gastrointestinal phenotype of Fabry disease in a patient with pseudoobstruction syndrome","volume":"4","author":"Buda","year":"2012","journal-title":"JIMD Rep."},{"key":"10.1016\/j.gene.2017.10.064_bb0035","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00109-005-0656-2","article-title":"Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population","volume":"83","author":"Dobrovolny","year":"2005","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.gene.2017.10.064_bb0040","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ajmg.a.30123","article-title":"Inheritance of most X-linked traits is not dominant or recessive, just X-linked","volume":"129A","author":"Dobyns","year":"2004","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.gene.2017.10.064_bb0045","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cge.12613","article-title":"X-chromosome inactivation in female patients with Fabry disease","volume":"89","author":"Echevarria","year":"2016","journal-title":"Clin. Genet."},{"key":"10.1016\/j.gene.2017.10.064_bb0050","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.gene.2012.06.013","article-title":"X-inactivation in Fabry disease","volume":"505","author":"Elstein","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.gene.2017.10.064_bb0055","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF03401671","article-title":"Fabry disease: thirty-five mutations in the alpha-galactosidase A gene in patients with classic and variant phenotypes","volume":"3","author":"Eng","year":"1997","journal-title":"Mol. Med."},{"key":"10.1016\/j.gene.2017.10.064_bb0060","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10545-007-0521-2","article-title":"Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry","volume":"30","author":"Eng","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.gene.2017.10.064_bb0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.gene.2017.10.064_bb0070","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ymgme.2009.10.178","article-title":"A validated disease severity scoring system for Fabry disease","volume":"99","author":"Giannini","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.gene.2017.10.064_bb0075","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1073\/pnas.85.15.5605","article-title":"Absence of methylation of a CpG-rich region at the 5\u2032 end of the MIC2 gene on the active X, the inactive X, and the Y chromosome","volume":"85","author":"Goodfellow","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2017.10.064_bb0080","article-title":"X-chromosome inactivation and its implications for human disease","author":"Gribnau","year":"2017","journal-title":"bioRxiv"},{"key":"10.1016\/j.gene.2017.10.064_bb0085","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.4238\/2014.August.28.19","article-title":"Pedigree analysis of Mexican families with Fabry disease as a powerful tool for identification of heterozygous females","volume":"13","author":"Guti\u00e9rrez-Amavizca","year":"2014","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.gene.2017.10.064_bb0090","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.nmd.2015.03.005","article-title":"Early onset cardiomyopathy in females with Danon disease","volume":"25","author":"Hedberg Oldfors","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.gene.2017.10.064_bb0095","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ymgme.2010.06.002","article-title":"Age adjusting severity scores for Anderson-Fabry disease","volume":"101","author":"Hughes","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.gene.2017.10.064_bb0100","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1399-0004.2010.01574.x","article-title":"Female Hunter syndrome caused by a single mutation and familial XCI skewing: implications for other X-linked disorders","volume":"80","author":"Kloska","year":"2011","journal-title":"Clin. Genet."},{"key":"10.1016\/j.gene.2017.10.064_bb0105","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1034\/j.1399-0004.2000.580311.x","article-title":"Identification of four novel mutations in five unrelated Korean families with Fabry disease","volume":"58","author":"Lee","year":"2000","journal-title":"Clin. Genet."},{"key":"10.1016\/j.gene.2017.10.064_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-016-0473-4","article-title":"Multicenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry disease","volume":"11","author":"Lenders","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.gene.2017.10.064_bb0115","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males","volume":"38","author":"MacDermot","year":"2001","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.gene.2017.10.064_bb0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/08035320600618809","article-title":"Disease manifestations and X inactivation in heterozygous females with Fabry disease","volume":"95","author":"Maier","year":"2006","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.gene.2017.10.064_bb0125","series-title":"GeneReviews(\u00ae) [Internet]","article-title":"Fabry disease","author":"Mehta","year":"2002"},{"key":"10.1016\/j.gene.2017.10.064_bb0130","doi-asserted-by":"crossref","DOI":"10.1093\/qjmed\/hcq117","article-title":"Fabry disease: a review of current management strategies","author":"Mehta","year":"2010","journal-title":"QJM"},{"key":"10.1016\/j.gene.2017.10.064_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/jmg.40.8.e103","article-title":"Fabry disease: molecular studies in Italian patients and X inactivation analysis in manifesting carriers","volume":"40","author":"Morrone","year":"2003","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.gene.2017.10.064_bb0140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ymgme.2016.10.006","article-title":"Plasma LysoGb3: a useful biomarker for the diagnosis and treatment of Fabry disease heterozygotes","volume":"120","author":"Nowak","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.gene.2017.10.064_bb0145","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.clinbiochem.2014.02.014","article-title":"Fabry disease: a new approach for the screening of females in high-risk groups","volume":"47","author":"Pasqualim","year":"2014","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.gene.2017.10.064_bb0150","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/jmg.33.8.682","article-title":"Uneven X inactivation in a female monozygotic twin pair with Fabry disease and discordant expression of a novel mutation in the alpha-galactosidase A gene","volume":"33","author":"Redonnet-Vernhet","year":"1996","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.gene.2017.10.064_bb0155","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s004390000382","article-title":"Age- and tissue-specific variation of X chromosome inactivation ratios in normal women","volume":"107","author":"Sharp","year":"2000","journal-title":"Hum. Genet."},{"key":"10.1016\/j.gene.2017.10.064_bb0160","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/sj.bmt.1702170","article-title":"Buccal swabs but not mouthwash samples can be used to obtain pretransplant DNA fingerprints from recipients of allogeneic bone marrow transplants","volume":"25","author":"Thiede","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.gene.2017.10.064_bb0165","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/GIM.0b013e3181bb05bb","article-title":"Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry","volume":"11","author":"Waldek","year":"2009","journal-title":"Genet. Med."},{"key":"10.1016\/j.gene.2017.10.064_bb0170","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1012993305223","article-title":"Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes","volume":"24","author":"Whybra","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.gene.2017.10.064_bb0175","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-0004.2004.00219.x","article-title":"The Mainz Severity Score Index: a new instrument for quantifying the Anderson - Fabry disease phenotype, and the response of patients to enzyme replacement therapy","volume":"65","author":"Whybra","year":"2004","journal-title":"Clin. Genet."},{"key":"10.1016\/j.gene.2017.10.064_bb0180","series-title":"Measurement of Disease Severity and Progression in Fabry Disease, Fabry Disease: Perspectives From 5Years of FOS","author":"Whybra","year":"2006"},{"key":"10.1016\/j.gene.2017.10.064_bb0185","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.fertnstert.2014.03.010","article-title":"X-chromosome inactivation in female newborns conceived by assisted reproductive technologies","volume":"101","author":"Wu","year":"2014","journal-title":"Fertil. Steril."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111917309095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111917309095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T18:26:48Z","timestamp":1536258408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111917309095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":37,"alternative-id":["S0378111917309095"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2017.10.064","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Female Fabry disease patients and X-chromosome inactivation","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2017.10.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}